VYNE Therapeutics Stock (NASDAQ: VYNE) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 107.523K |
Day Range | - - - |
52 Wk Range | 1.670 - 8.730 |
Market Cap | $38.192M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 56 |
Short Interest | 0.61% |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of VYNE Therapeutics (NASDAQ: VYNE) through any online brokerage.
Other companies in VYNE Therapeutics’s space includes: Cumberland (NASDAQ:CPIX), Iterum Therapeutics (NASDAQ:ITRM), SCYNEXIS (NASDAQ:SCYX), Jaguar Health (NASDAQ:JAGX) and CalciMedica (NASDAQ:CALC).
The latest price target for VYNE Therapeutics (NASDAQ: VYNE) was reported by HC Wainwright & Co. on Thursday, February 29, 2024. The analyst firm set a price target for 5.75 expecting VYNE to rise to within 12 months (a possible 112.26% upside). 5 analyst firms have reported ratings in the last year.
The stock price for VYNE Therapeutics (NASDAQ: VYNE) is $2.7089 last updated April 24, 2024 at 4:32 PM EDT.
There are no upcoming dividends for VYNE Therapeutics.
VYNE Therapeutics’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for VYNE Therapeutics.
VYNE Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.